Precision Medicine

The diagnostic reality for nearly ten percent of patients with advanced solid tumors involves a debilitating accumulation of abdominal fluid that traditionally signals the final, most resistant stage of oncological progression. For years, this fluid, known as malignant ascites, was treated

Professor Alok Mishra of the Norwegian University of Science and Technology argues that a narrow focus on computational efficiency ignores the ecological damage caused by AI infrastructure. This perspective is vital as artificial intelligence transitions from an experimental novelty to the primary

Transcriptomic profiling reveals that suppressing β-catenin in specific mutant cells leads to an overwhelming accumulation of ubiquitinated proteins and cellular stress. This biological response marks a turning point in the treatment of advanced endometrial cancer, which remains a leading cause of

With a focus on advanced machine learning, Isomorphic Labs is attempting to cut years off the timeline required to bring life-saving drugs from the lab to patients. This ambitious goal is currently being met with unprecedented investor enthusiasm, as reports indicate the Alphabet spinoff is seeking

Computational science and digital platforms are being leveraged to bridge the gap between active cancer treatment and the often-neglected survivorship phase. This shift represents a fundamental evolution in oncology, moving away from episodic, clinic-based interactions toward a more fluid and

The high risk of overfitting in medical machine learning is mitigated through rigorous variance screening and Pearson correlation to remove redundant imaging data. This technical principle is now at the forefront of efforts to resolve one of the most persistent dilemmas in thoracic oncology: the